Food effect studies and drug label recommendations: A review of recently approved oncology products.

被引：1
|
作者：
Farha, Mark
Masson, Eric
Tomkinson, Helen
Mugundu, Ganesh
机构：
[1] AstraZeneca, Waltham, MA USA
[2] AstraZeneca, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA
[3] AstraZeneca, Early Clin Dev, Quantitat Clin Pharmacol, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Effect of high pressure processing on meat and meat products. A review
    Sukmanov, Valerii
    Ma Hanjun
    Li, Yan-ping
    UKRAINIAN FOOD JOURNAL, 2019, 8 (03) : 448 - 469
  • [32] Commentary on "A review of new drugs approved by the food and drug administration in 2022"
    Sharma, Kopal
    Sharma, Amit
    Kapadia, Rupa
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (03) : 1133 - 1133
  • [33] REVIEW AND RECOMMENDATIONS OF ENDPOINTS FOR REAL-WORLD STUDIES IN ONCOLOGY
    Julian, G. S.
    Duva, A.
    Santana, P.
    Cavalcanti, H. E.
    Ballalai, A. F.
    VALUE IN HEALTH, 2018, 21 : S90 - S90
  • [34] Active packaging technologies for clean label food products: a review
    Singh, Ajit Kumar
    Ramakanth, Dakuri
    Kumar, Avinash
    Lee, Youn Suk
    Gaikwad, Kirtiraj K.
    JOURNAL OF FOOD MEASUREMENT AND CHARACTERIZATION, 2021, 15 (05) : 4314 - 4324
  • [35] Active packaging technologies for clean label food products: a review
    Ajit Kumar Singh
    Dakuri Ramakanth
    Avinash Kumar
    Youn Suk Lee
    Kirtiraj K. Gaikwad
    Journal of Food Measurement and Characterization, 2021, 15 : 4314 - 4324
  • [36] Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
    Tsimberidou, Apostolia-Maria
    Braiteh, Fadi
    Stewart, David J.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6243 - 6250
  • [37] Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Study
    Mross, Klaus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 407 - 408
  • [38] PAN-CANADIAN ONCOLOGY DRUG REVIEW RECOMMENDATIONS FOR CANCER PRODUCTS WITHOUT STATISTICALLY SIGNIFICANT OVERALL SURVIVAL DATA
    Samjoo, I. A.
    Patel, L.
    Cameron, C.
    Blazevic, C.
    Grima, D.
    VALUE IN HEALTH, 2016, 19 (03) : A167 - A168
  • [39] Association between oncology drug review times and public funding recommendations
    Gagnon, Richard
    Wong, Chelsea
    Taguedong, Eddy
    Maneesh, Parthiv
    Karim, Safiya
    Lee-Ying, Richard M.
    Ezeife, Doreen Anuli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [40] Off-label drug use in oncology: a systematic review of literature
    Saiyed, M. M.
    Ong, P. S.
    Chew, L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (03) : 251 - 258
12345